Home
|
Help
|
Contact
Sign in
WPRIM Management System>
DCMS
>
Chinese Medical Journal
>
2007
>
120
>
6
Volume:
120
Issue:
6
1. Perivascular epithelioid cell tumor of the uterus: report of three cases.
Page:526—528
2. R5 to X4 coreceptor switch of human immunodeficiency virus type 1 B' and B'/C recombinant subtype isolates in China.
Page:522—525
3. Smad4 and ERK2 stimulated by transforming growth factor beta1 in rhabdomyosarcoma.
Page:515—521
4. Endogenous danger signals trigger hepatic ischemia/reperfusion injury through toll-like receptor 4/nuclear factor-kappa B pathway.
Page:509—514
5. Encapsidating artificial human papillomavirus-16 mE7 protein in human papillomavirus-6b L1/L2 virus like particles..
Page:503—508
6. Enhancement of DNA vaccine-induced immune responses by a 72-bp element from SV40 enhancer.
Page:496—502
7. Effect of fibroblast growth factor 9 on Runx2 gene promoter activity in MC3T3-E1 and C2C12 cells.
Page:491—495
8. Dynamic changes in the expression of growth factor receptors in the myocardium microvascular endothelium after murine myocardial infarction.
Page:485—490
9. Elevation of tumor necrosis factor-alpha, interleukin-1beta and interleukin-6 levels in aortic intima of Chinese Guizhou minipigs with streptozotocin-induced diabetes.
Page:479—484
10. PET/CT imaging of delayed radiation encephalopathy following radiotherapy for nasopharyngeal carcinoma.
Page:474—478
11. XIAP as a prognostic marker of early recurrence of nonmuscular invasive bladder cancer.
Page:469—473
12. Modified conditioning regimen busulfan-cyclophosphamide followed by allogeneic stem cell transplantation in patients with multiple myeloma.
Page:463—468
13. Weekly gemcitabine as a radiosensitiser for the treatment of brain metastases in patients with non-small cell lung cancer: phase I trial.
Page:458—462
14. A 26-year clinical observation of splenic auto-transplantation and oesophageal transection anastomosis: a new treatment strategy in patients with portal hypertension.
Page:452—457
15. Age-based clinical and angiographic outcomes after sirolimus-eluting stent implantation in patients with coronary artery disease.
Page:447—451